Across the global pharmaceutical landscape, a staggering number of potentially life-changing therapies for rare diseases lie dormant, gathering dust on…
Read More
Natural Selection within the Testes Favors Disease-Causing Mutations as Men Age Increasing Genetic Risks for Future Generations
The biological landscape of the male reproductive system is far more competitive and dynamic than previously understood, according to a…
Read More
Measles Research Intensifies Amidst Declining Vaccination Rates: Scientists Explore Antiviral Treatments to Combat Resurgent Disease
The resurgence of measles, a highly contagious viral illness, is prompting a renewed focus on therapeutic interventions beyond vaccination. While…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health Strategies
In his latest clinical update on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive overview…
Read More
New Ancient DNA Analysis Rewrites Understanding of Disease Devastation During Napoleon’s 1812 Russian Retreat
For over two centuries, the precise causes of the catastrophic disease outbreaks that decimated Napoleon’s Grande Armée during its ill-fated…
Read More
Navigating the Diagnostic Labyrinth: Fragmentation Hinders Rare Disease Progress Despite Scientific Leaps
The journey from the first symptom of a rare disease to a confirmed diagnosis, often referred to as the "diagnostic…
Read More
Cancer Driving Mutations in Brain Immune Cells Linked to Alzheimer’s Disease Progression and Risk
The traditional understanding of Alzheimer’s disease has long centered on the accumulation of amyloid-beta plaques and tau tangles within the…
Read More
Europe Must Rethink Funding and De-Risk Assets to Secure its Rare Disease Research Pipeline
The 13th European Conference on Rare Diseases and Orphan Products, held in Prague, Czech Republic, from June 3-4, 2026, served…
Read MoreHow CTF is trying to rescue pharma’s shelved rare disease drugs
More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…
Read More
Eli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Revolutionize Kidney Disease Treatment Through Advanced Genetic Medicine
Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…
Read MoreYOU MAY HAVE MISSED
